Medical news and careers, clearly connected
CareZelo
English
Menu

Mga update sa pampublikong kalusugan

Due sa loob ng 39 arawPampublikong kalusuganCanada

Sandoz rabeprazole 20 mg supply disruption expected until early December

Sandoz Canada reports its rabeprazole sodium 20 mg enteric-coated tablet (DIN 02314185) faces an anticipated shortage from Oct 26 to Dec 4, 2026, after a disruption in the manufacture of the drug.

Rabeprazole is a commonly prescribed stomach-acid drug — prescribers and pharmacies should plan alternatives while the shortage is expected.

Shortage expected to end: Dis 4, 2026 Lahat ng deadline

Magtanong tungkol sa buod na ito

Ang mga sagot ay isinulat ng AI mula sa buod na ito at maaaring magkamali. Suriin ang orihinal na source bago kumilos.

2 libreng tanong bawat araw nang walang account. Ang mga miyembro ay maaaring magtanong nang madalas hangga't gusto nila, nang libre.

Hindi ito medikal, legal, o immigration advice. Ang mga tanong ay pinananatiling anonymous upang mapabuti ang aming mga buod.

Basahin ang orihinal

Opisyal na source: Sandoz rabeprazole 20 mg supply disruption expected until early December (bubukas sa bagong tab) — Health Product Shortages Canada

Mag-ulat ng problema

Due sa loob ng 20 arawPampublikong kalusuganCanada

Accel Pharma reports upcoming two-week shortage of ondansetron 8 mg tablets

Accel Pharma reports its ondansetron orally-disintegrating tablet 8 mg (ACCEL-ONDANSETRON ODT, DIN 02535327) faces an anticipated shortage from Nov 1 to Nov 15, 2026, caused by a shortage of an active ingredient.

Ondansetron is a widely used anti-nausea drug — pharmacies should check stock and alternatives before the anticipated shortage starts Nov 1.

Opisyal na source: Health Product Shortages Canada (bubukas sa bagong tab)

Due sa loob ng 20 arawPampublikong kalusuganCanada

Accel Pharma reports upcoming two-week shortage of ondansetron 4 mg tablets

Accel Pharma reports its ondansetron orally-disintegrating tablet 4 mg (ACCEL-ONDANSETRON ODT, DIN 02535319) faces an anticipated shortage from Nov 1 to Nov 15, 2026, caused by a shortage of an active ingredient.

Ondansetron is a widely used anti-nausea drug — pharmacies should check stock and alternatives before the anticipated shortage starts Nov 1.

Opisyal na source: Health Product Shortages Canada (bubukas sa bagong tab)

Due sa loob ng 18 arawPampublikong kalusuganCanada

Sandoz dexamethasone injection supply faces temporary shortage through mid-November

Sandoz Canada reports its dexamethasone sodium phosphate injection 10 mg/mL (DIN 00874582), for intravenous, intramuscular or intrasynovial use, faces an anticipated shortage from Oct 26 to Nov 13, 2026, driven by increased demand.

Dexamethasone injection is a staple steroid in hospitals and clinics — care teams should check stock before the anticipated shortage bites.

Opisyal na source: Health Product Shortages Canada (bubukas sa bagong tab)

Due sa loob ng 11 arawPampublikong kalusuganCanada

Sandoz reports supply shortage of sufentanil injection through early November

Sandoz Canada reports its sufentanil citrate injection 50 mcg (DIN 02244147), for epidural or intravenous use, is in an actual shortage that began Oct 13, 2026 and is expected to run until Nov 6, 2026, driven by increased demand.

Sufentanil is used in anaesthesia and pain care — hospitals should confirm supply and alternatives while the shortage runs.

Opisyal na source: Health Product Shortages Canada (bubukas sa bagong tab)